Patents by Inventor Jason Cameron

Jason Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8822417
    Abstract: Variants of a parent albumin having altered plasma half-life compared with a parent albumin are described. Fusion polypeptides and conjugates including the variant albumin are also described. Embodiments include, but are not limited to, a polypeptide which is a variant of albumin, including one or more alterations at one or more positions corresponding to 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119 and 120 in SEQ ID NO: 2.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: September 2, 2014
    Assignee: Novozymes Biopharma DIC A/S
    Inventors: Jan Terje Andersen, Bjorn Dalhus, Inger Sandlie, Jason Cameron, Andrew Plumridge, Esben Peter Friis, Karen Delahay
  • Publication number: 20140234311
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: April 25, 2014
    Publication date: August 21, 2014
    Applicant: NOVOZYMES BIOPHARMA DK A/S
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • Patent number: 8748380
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: June 10, 2014
    Assignee: Novozymes Biopharma DK A/S
    Inventors: Andrew Plumridge, Darrell Sleep, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • Publication number: 20140128326
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: November 8, 2013
    Publication date: May 8, 2014
    Applicants: Novozymes Biopharma DK A/S, University of OSLO, Novozymes Biopharma UK Limited, Novozymes A/S
    Inventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
  • Patent number: 8707515
    Abstract: A strain relief device for securing three radially arrayed flat cables coming into a closure includes a body having three armatures extending radially. Each armature includes at least two cantilevered segments extending from the at least one armature in opposing directions. At least one cable may be received in a receiving area partially defined by the armature and the cantilevered segment. Compressive force acting on the strain relief device secures the cables in the receiving area relative to the strain relief device.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: April 29, 2014
    Assignee: Corning Cable Systems
    Inventors: Jason Cameron Payne, Karyne Poissant Prevratil, Howard Clark Schwartz
  • Publication number: 20140044400
    Abstract: A fiber management frame for a fiber optic closure having a removable tray holder configured to mount a fiber optic tray offset from a fiber management interface. The tray holder has optical fibers mounted thereon and can be mounted and/or removed from the fiber management interface without interfering with optical fibers mounted on the fiber management interface. The fiber management interface defines a first slack storage area for a first group of optical fibers. The removable tray holder defines a second slack storage area for a second group of optical fibers offset from the fiber management interface. The fiber optic tray can be mounted to or removed from the fiber management interface without interfering with the first group of optical fibers.
    Type: Application
    Filed: May 30, 2013
    Publication date: February 13, 2014
    Applicant: Corning Cable Systems LLC
    Inventors: Salvador Anguiano, Jason Cameron Payne, Karyne Poissant Prevratil, John Joseph Stillwell
  • Patent number: 8607837
    Abstract: An apparatus for stripping metal from a cathode plate, the apparatus comprising stripping means adapted for positioning between the metal and the cathode plate in order to separate the metal from the cathode plate, and wherein movement of the stripping means is achieved through movement of a robotic arm.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: December 17, 2013
    Assignee: Xstrata Technology Pty Ltd.
    Inventors: Anthony John Ruddell, Per Ola Eriksson, Jason Cameron Schulte, Gavin Jeffery Tang Sue Yek
  • Publication number: 20130225496
    Abstract: The invention relates to variants of albumin. The invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of preparing the variants and to methods of using the variants.
    Type: Application
    Filed: November 1, 2011
    Publication date: August 29, 2013
    Applicant: Novozymes Biopharma DK A/S
    Inventors: Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • Publication number: 20130028930
    Abstract: The application discloses albumin derivatives comprising or consisting of domain III and at least one further domain wherein the derivative or variant is not a naturally occurring albumin derivative or variant. The derivatives may be used in conjugates and fusion polypeptides.
    Type: Application
    Filed: April 8, 2011
    Publication date: January 31, 2013
    Applicant: NOVOZYMES BIOPHARMA DK A/S
    Inventors: Andrew Plumridge, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Jason Cameron, Leslie Evans, Steven Athwal, Elizabeth Allan, Esben Peter Friis
  • Publication number: 20120322739
    Abstract: The invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: May 4, 2012
    Publication date: December 20, 2012
    Applicants: Novozymes Biopharma UK Limited, Novozymes Biopharma DK A/S, Novozymes A/S, University of Oslo
    Inventors: Jan Terje Andersen, Bjorn Dalhus, Inger Sandlie, Jason Cameron, Andrew Plumridge, Esben Peter Friis, Karen Delahay
  • Publication number: 20120297574
    Abstract: A strain relief device for securing three radially arrayed flat cables coming into a closure includes a body having three armatures extending radially. Each armature includes at least two cantilevered segments extending from the at least one armature in opposing directions. At least one cable may be received in a receiving area partially defined by the armature and the cantilevered segment. Compressive force acting on the strain relief device secures the cables in the receiving area relative to the strain relief device.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 29, 2012
    Inventors: Jason Cameron Payne, Karyne Poissant Prevratil, Howard Clark Schwartz
  • Publication number: 20120220530
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: November 1, 2010
    Publication date: August 30, 2012
    Applicant: Novozymes Biopharma DK A/S
    Inventors: Andrew Plumridge, Darrell Sleep, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • Publication number: 20120149873
    Abstract: An improved method for purifying albumin, a variant or fragment thereof, a fusion protein comprising albumin, a variant or fragment thereof, or a conjugate comprising albumin, a variant or fragment thereof is disclosed.
    Type: Application
    Filed: May 7, 2010
    Publication date: June 14, 2012
    Applicant: NOVOZYMES BIOPHARMA DK A/S
    Inventors: Lee Edward Blackwell, Jason Cameron, Phillip Harvey Morton
  • Publication number: 20120106912
    Abstract: A fiber optic module having a module housing and a module sub-assembly. The module housing defines at least an interior space, at least one adapter aperture and at least one input aperture. The module sub-assembly defines at least one fiber optic cable, for example, passing through the at least one input aperture, at least one multi-fiber connector on an end of the fiber optic cable, and at least one single fiber connector on an opposite end of the fiber optic cable, the multi-fiber connector being in optical communication with the at least one single fiber connector, the multi-fiber connector capable of flexing on the at least one fiber optic cable relative to the module housing.
    Type: Application
    Filed: October 26, 2011
    Publication date: May 3, 2012
    Inventors: Daniel Scott McGranahan, Kenneth Charles Simonson, Jason Cameron Payne
  • Publication number: 20120037319
    Abstract: An apparatus for stripping metal from a cathode plate, the apparatus comprising stripping means adapted for positioning between the metal and the cathode plate in order to separate the metal from the cathode plate, and wherein movement of the stripping means is achieved through movement of a robotic arm.
    Type: Application
    Filed: February 5, 2010
    Publication date: February 16, 2012
    Applicant: Xstrata Technology Pty Ltd.
    Inventors: Anthony John Ruddell, Per Ola Eriksson, Jason Cameron Schulte, Gavin Jeffery Tang Sue Yek
  • Publication number: 20110313133
    Abstract: Based on the three-dimensional structure of albumin, the inventors have designed variant polypeptides (muteins) which have one or more cysteine residues with a free thiol group (hereinafter referred to as “thio-albumin”). The variant polypeptide may be conjugated through the sulphur atom of the cysteine residue to a conjugation partner such as a bioactive compound.
    Type: Application
    Filed: February 11, 2010
    Publication date: December 22, 2011
    Applicants: Novozymes A/S, Novozymes BioPharma DK A/S
    Inventors: Christopher John Arthur Finnis, Joanna Mary Hay, Esben Peter Friis, Jason Cameron, Darrell Sleep
  • Publication number: 20110301329
    Abstract: A process is provided for the preparation of a highly pure albumin solution the process comprising subjecting albumin (preferably expressed and secreted by transformed yeast) to a series of chromatographic steps. Preferably, the process comprises the steps of positive mode cation exchange chromatography, positive mode anion exchange chromatography, positive mode affinity chromatography, negative mode affinity chromatography (preferably using immobilised aminophenylboronic acid), negative mode cation exchange chromatography, and negative or positive mode anion exchange chromatography. A process for reducing the level of nickel in an albumin solution is also disclosed, as is a recombinant albumin coding sequence comprising two or more in-frame translation stop codons.
    Type: Application
    Filed: July 1, 2011
    Publication date: December 8, 2011
    Applicant: Novozymes Biopharma DK A/S
    Inventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
  • Publication number: 20110294988
    Abstract: A process for purifying a transferrin solution and the product of the purification process. A process for producing transferrin and the product of the production process. Use of the transferrin in cell culture, as a pharmaceutical ingredient, as a pharmaceutical product and in a cell culture medium.
    Type: Application
    Filed: February 5, 2010
    Publication date: December 1, 2011
    Applicant: Novozymes Bio Pharma DK A/S
    Inventors: Lee Edward Blackwell, Jason Cameron, Phillip Harvey Morton
  • Patent number: 7993877
    Abstract: A process is provided for the preparation of a highly pure recombinant albumin solution having a nickel ion content of less than 100 ng per gram of albumin. The process comprises subjecting a recombinant albumin to a series of chromatography, concentration, and diafiltration steps.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: August 9, 2011
    Assignee: Novozymes Biopharma DK A/S
    Inventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
  • Publication number: 20090171070
    Abstract: A process is provided for the preparation of a highly pure recombinant albumin solution having a nickel ion content of less than 100 ng per gram of albumin. The process comprises subjecting a recombinant albumin to a series of chromatography, concentration, and diafiltration steps.
    Type: Application
    Filed: September 9, 2008
    Publication date: July 2, 2009
    Applicant: NOVOZYMES BIOPHARMA UK LIMITED
    Inventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron